Robert Baird, RN, MSA, president of the National Cancer Treatment Alliance, discusses potential issues employers can avoid by direct contracting with providers.
Robert Baird, RN, MSA, president of the National Cancer Treatment Alliance, discusses potential protections self-insured employers could seeing from direct contracting, including the elimination of tactics from pharmacy benefit managers that can affect patient outcomes.
Transcript
What should employers know about direct contracting in cancer care?
[They should know] that they do have an opportunity, and they do have an opportunity to take more control of their own health care costs and their health care benefits in relation to cancer. And this will allow them to eliminate a lot of the burden of some tactics by pharmacy benefit managers and insurance companies, such as preauthorization, precertification, white bagging, or brown bagging, that can cause harm to patients and also interfere with the doctor-patient relationships. And our goal is to connect them with community oncology practices, where employees live and work.
LLMs Show Promise, But Challenges Remain in Improving Inefficient Clinical Trial Screening
July 31st 2025Large language models (LLMs) such as GPT-3.5 and GPT-4 may offer a solution to the costly and inefficient process of manual clinical trial screening, which is often hindered by the inability of structured electronic health record data to capture all necessary criteria.
Read More
Trends in Insulin Out-of-Pocket Costs and Use Disparities, 2008-2021
July 31st 2025Given trends in cost and use, insulin out-of-pocket cost reduction policies would be more efficient if they targeted members in high-deductible health plans with savings options and low-income patients.
Read More
The Legal Architecture of Psychedelic Therapy: Risks, Responsibilities, and Reimbursement Realities
July 30th 2025Key legal, ethical, and compliance considerations for managed care professionals navigating the evolving landscape of psychedelic-assisted therapy include regulatory risks, data privacy challenges, reimbursement limitations, and the need for culturally informed care models.
Read More